Combined detection of the ActRII‐Fc fusion proteins Sotatercept (ActRIIA‐Fc) and Luspatercept (modified ActRIIB‐Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC‐MS/MS-Reference-Cited by-同舟云学术

Combined detection of the ActRII‐Fc fusion proteins Sotatercept (ActRIIA‐Fc) and Luspatercept (modified ActRIIB‐Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC‐MS/MS

Published:2018-10-30 Issue:11-12 Volume:10 Page:1714-1721
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Walpurgis Katja¹^ORCID,Thomas Andreas¹,Lange Tobias¹,Reichel Christian²^ORCID,Geyer Hans¹,Thevis Mario¹³^ORCID

Affiliation:

1. Center for Preventive Doping Research/Institute of BiochemistryGerman Sport University Cologne Cologne Germany

2. Doping Control LaboratoryAIT Seibersdorf Laboratories Seibersdorf Austria

3. European Monitoring Center for Emerging Doping Agents (EuMoCEDA) Cologne/Bonn Germany

Funder

Manfred-Donike Institute for Doping Analysis (Cologne, Germany)

Federal Ministry of the Interior of the Federal Republic of Germany

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.2513

Reference30 articles.

1. Activin signaling as an emerging target for therapeutic interventions;Tsuchida K;Cell Commun Signal,2009

2. An activin receptor II A ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin

3. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis

4. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia

5. TaherA.Thalassemia. Elsevier Health Sciences: An Issue of Hematology/Oncology Clinics of North America.2018.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in mass spectrometry for the detection of doping;Expert Review of Proteomics;2024-01-17

2. High‐throughput untargeted screening of biotherapeutic macromolecules in equine plasma by UHPLC‐HRMS/MS: Application to monoclonal antibodies and Fc‐fusion proteins for doping control;Drug Testing and Analysis;2023-06-20

3. Detection of activin receptor type IIA and IIB‐Fc fusion proteins by automated capillary immunoassay;Drug Testing and Analysis;2022-10-25

4. Detection of erythropoiesis stimulating agent Luspatercept after administration to healthy volunteers for antidoping purposes;Drug Testing and Analysis;2022-07-07

5. Olympic anti-doping laboratory: the analytical technological road from 2016 Rio De Janeiro to 2021 Tokyo;Bioanalysis;2021-10